Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to intimation dated November 8, 2025 to the Stock exchanges regarding Earning call in respect of the unaudited (Standalone and Consolidated) Financial Results of the company for Second Quarter and half year ended September 30, 2025, Concord Biotech has informed that the said Earning Call was held on 14th November, 2025 at 03:30 PM (IST). The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: https://concordbiotech.com/wp-content/uploads/2025/11/Q2FY26-EarningCall-Audio.mp3
The above information is a part of company’s filings submitted to BSE.
